FDA NDC Directory · JSON-LD · Markdown

ARBLI

NDC 83245-053 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namelosartan potassium
Labeler / ManufacturerScienture LLC
Marketing categoryNew Drug Application (innovator) · App NDA218772
Dosage form / routeSUSPENSION · ORAL
Active ingredientsLOSARTAN POTASSIUM (10 mg/mL)
Marketing started20250319
Package count1

External sources

Source: openFDA. Public-domain (CC0).